NICE or Nasty? Access and Reimbursement of Multiple Sclerosis Medicines in the UK
通常価格
¥1,474 JPY
通常価格
セール価格
¥1,474 JPY
単価
あたり
税込み。
受取状況を読み込めませんでした
NICE (National Institute for Health and Clinical Excellence) reviews the cost effectiveness of medicines for the treatment of multiple sclerosis (annual cost per patient 10,000-18,000) and does not authorize their use within the UK National Health Service. However, an agreement between the manufacturers and the Department of Health is reached on an innovative risk sharing scheme.
【書誌情報】
ページ数:32ページ
サイズ:A4
商品番号:HBSP-INS483
発行日:2006/7/1
登録日:2014/12/11
